Yield10 Price Earnings To Growth Ratio from 2010 to 2024

YTEN Stock  USD 0.24  0.01  4.35%   
Yield10 Bioscience Price Earnings To Growth Ratio yearly trend continues to be very stable with very little volatility. Price Earnings To Growth Ratio is likely to grow to 0 this year. During the period from 2010 to 2024, Yield10 Bioscience Price Earnings To Growth Ratio quarterly data regression pattern had sample variance of  0.01 and median of  0.01. View All Fundamentals
 
Price Earnings To Growth Ratio  
First Reported
2010-12-31
Previous Quarter
0.00386251
Current Value
0.004056
Quarterly Volatility
0.09148719
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Yield10 Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yield10 main balance sheet or income statement drivers, such as Interest Expense of 44.8 K, Total Revenue of 57 K or Other Operating Expenses of 17.8 M, as well as many exotic indicators such as Price To Sales Ratio of 30.11, Dividend Yield of 0.0 or Days Sales Outstanding of 26.58. Yield10 financial statements analysis is a perfect complement when working with Yield10 Bioscience Valuation or Volatility modules.
  
This module can also supplement various Yield10 Bioscience Technical models . Check out the analysis of Yield10 Bioscience Correlation against competitors.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.

Latest Yield10 Bioscience's Price Earnings To Growth Ratio Growth Pattern

Below is the plot of the Price Earnings To Growth Ratio of Yield10 Bioscience over the last few years. It is Yield10 Bioscience's Price Earnings To Growth Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Yield10 Bioscience's overall financial position and show how it may be relating to other accounts over time.
Price Earnings To Growth Ratio10 Years Trend
Very volatile
   Price Earnings To Growth Ratio   
       Timeline  

Yield10 Price Earnings To Growth Ratio Regression Statistics

Arithmetic Mean0
Geometric Mean0.03
Coefficient Of Variation2,764
Mean Deviation0.06
Median0.01
Standard Deviation0.09
Sample Variance0.01
Range0.3923
R-Value(0.02)
Mean Square Error0.01
R-Squared0.0003
Significance0.95
Slope(0.0003)
Total Sum of Squares0.12

Yield10 Price Earnings To Growth Ratio History

2024 0.004056
2023 0.003863
2022 -0.0328
2021 0.0461
2020 0.0153
2019 0.0476
2018 0.0133

About Yield10 Bioscience Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Yield10 Bioscience income statement, its balance sheet, and the statement of cash flows. Yield10 Bioscience investors use historical funamental indicators, such as Yield10 Bioscience's Price Earnings To Growth Ratio, to determine how well the company is positioned to perform in the future. Although Yield10 Bioscience investors may use each financial statement separately, they are all related. The changes in Yield10 Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Yield10 Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Yield10 Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Yield10 Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Earnings To Growth Ratio 0  0 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:
Check out the analysis of Yield10 Bioscience Correlation against competitors.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Yield10 Stock analysis

When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Yield10 Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Revenue Per Share
0.008
Quarterly Revenue Growth
(1.00)
Return On Assets
(1.50)
Return On Equity
(15.08)
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.